Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
Clinical trial NCT00272493 · COMPLETED
Trial details
- NCT number
- NCT00272493
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2007-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.